TABLE 2.
In vitro antifungal susceptibility data for C. perlucidum isolatesa
| Antifungal agent | Patient | MIC (μg/ml) at 48/72 h | MLC (μg/ml) at 48/72 h |
|---|---|---|---|
| AMB | 1 | 0.25/0.25 | 0.25/0.25 |
| 2 | 0.25/0.25 | 0.25/0.25 | |
| ITC | 1 | ≤0.015/0.06 | |
| 2 | 0.06/0.06 | ||
| VRC | 1 | 0.5/0.5 | |
| 2 | 0.5/0.5 | ||
| POS | 1 | 0.125/0.125 | |
| 2 | 0.06/0.125 | ||
| CAS | 1 | 8/16 | |
| 2 | 16/32 |
As determined by the NCCLS M-38P method.